Product Pathways - Chromatin Regulation / Epigenetics
MED12 Antibody #4529
|4529S||100 µl (10 western blots)||---||In Stock||---|
|4529||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human, Mouse, Rat, Monkey||Endogenous||240||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Species predicted to react based on 100% sequence homology: Hamster, Bovine, Pig, Horse.
Specificity / Sensitivity
MED12 Antibody recognizes endogenous levels of total MED12 protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human MED12 protein. Antibodies are purified by protein A and peptide affinity chromatography.
The Mediator complex consists of about 25-30 proteins and is thought to facilitate transcription activation by acting as a molecular bridge between the RNA polymerase II (RNAPII) machinery and transcription factors (1). Mediator is recruited to target genes by transcription factors and plays an essential role in the recruitment and stabilization of the RNAPII transcription complex at promoters, as well as the activation of transcription post RNAPII recruitment (1-5). The Mediator complex also plays an important role in creating ‘chromatin loops’ that occur as a result of interactions between the transcription factor bound at distal enhancers and RNAPII bound at the proximal promoter, and works to sustain proper chromatin architecture during active transcription (6-8).
MED12 is part of the CDK8 submodule of the Mediator complex and is required for the stable interaction of this module with the rest of the Mediator complex (1,9). The CDK8 module has been shown to be both a negative and positive regulator of transcription depending on the gene context. The CDK8 module may repress transcription by inhibiting the ability of Mediator to recruit RNAPII (10). In addition, the MED12 subunit can recruit the methyltransferase G9a to methylate histone H3K9 to repress a subset of neuronal genes in non-neuronal cells (11). MED12 and the CDK8 module can also positively regulate transcription of Wnt-responsive genes through its interaction with β-catenin, and p53-regulated genes upon UV-induced DNA damage (1,9,12).
- Taatjes, D.J. (2010) Trends Biochem Sci 35, 315-22.
- Kornberg, R.D. (2005) Trends Biochem Sci 30, 235-9.
- Malik, S. and Roeder, R.G. (2005) Trends Biochem Sci 30, 256-63.
- Malik, S. et al. (2002) Mol Cell Biol 22, 5626-37.
- Wang, G. et al. (2005) Mol Cell 17, 683-94.
- Kagey, M.H. et al. (2010) Nature 467, 430-5.
- Park, S.W. et al. (2005) Mol Cell 19, 643-53.
- Chen, Z. et al. (2011) EMBO J 30, 2405-19.
- Kim, S. et al. (2006) J Biol Chem 281, 14066-75.
- Knuesel, M.T. et al. (2009) Genes Dev 23, 439-51.
- Ding, N. et al. (2008) Mol Cell 31, 347-59.
- Galbraith, M.D. et al. (2010) Transcription 1, 4-12.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 4101 CDK8 (G398) Antibody
- 4106 CDK8 (P455) Antibody
- 4735 Phospho-Rpb1 CTD (Ser2/5) Antibody
- 2629 Rpb1 CTD (4H8) Mouse mAb
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.